SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-017793
Filing Date
2023-05-16
Accepted
2023-05-16 16:15:46
Documents
16
Period of Report
2023-02-28
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 48846
2 ex23-1.htm EX-23.1 3891
3 ex99-1.htm EX-99.1 54312
4 ex99-2.htm EX-99.2 163686
5 ex23-1_001.jpg GRAPHIC 35482
  Complete submission text file 0001493152-23-017793.txt   526452

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE xtnt-20230228.xsd EX-101.SCH 3239
7 XBRL LABEL FILE xtnt-20230228_lab.xml EX-101.LAB 34916
8 XBRL PRESENTATION FILE xtnt-20230228_pre.xml EX-101.PRE 22797
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 4458
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34951 | Film No.: 23927693
SIC: 2836 Biological Products, (No Diagnostic Substances)